You are here

tremelimumab

AstraZeneca gets first okay for CTLA4 drug tremelimumab

Pharmaphorum

Mon, 10/24/22 - 10:50 am

Here's What AstraZeneca's Recent FDA News Means for Shareholders

Motley Fool

Mon, 05/30/22 - 10:15 am

After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA

Endpoints

Mon, 04/25/22 - 10:20 am

priority review

ASCO-GI – immuno-oncology makes progress in liver cancer

EP Vantage

Fri, 01/21/22 - 10:37 am

AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer

NASDAQ

Fri, 10/15/21 - 11:03 am

clinical trials

WCLC: AstraZeneca's detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut win

Fierce Pharma

Fri, 09/10/21 - 11:05 am

metastatic non-small cell lung cancer

ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab?

Fierce Pharma

Sun, 05/31/20 - 11:58 pm

clinical trials

AstraZeneca Imfinzi combination fails advanced lung cancer study

Yahoo/Reuters

Wed, 08/21/19 - 09:31 am

advanced non-small cell lung cancer

AstraZeneca’s Mystic OS analysis paints tremelimumab as a dud in NSCLC

Fierce Biotech

Fri, 11/16/18 - 12:19 pm

clinical trials

non-small cell lung cancer

AstraZeneca lung cancer immunotherapy trial failure sends shares plunging

Stat

Thu, 07/27/17 - 09:59 am

immuno-oncology

clinical trials

Soriot skipping over to Teva ahead of MYSTIC results?

BioPharma Dive

Thu, 07/13/17 - 05:36 pm

Teva Pharmaceutical

Investors — and AstraZeneca CEO Pascal Soriot — are getting a tad nervous as MYSTIC data loom

Endpoints

Thu, 06/29/17 - 09:23 am

immuno-oncology

clinical trials

AstraZeneca angles for more competitive position in immuno-oncology

BioPharma Dive

Thu, 01/19/17 - 11:19 am

immuno-oncology

AstraZeneca delays PD-L1 data in rejig of phase 3 program

Fierce Biotech

Tue, 01/17/17 - 10:02 am

clinical trials

AstraZeneca's mesothelioma drug fails monotherapy testing

BioPharma Dive

Thu, 03/3/16 - 10:38 am

clinical trials

Closely watched AstraZeneca cancer drug fails in mesothelioma

Reuters

Mon, 02/29/16 - 11:13 am

clinical trials

AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study

Fierce Biotech

Tue, 02/9/16 - 09:00 am

metastatic non-small cell lung cancer

New data expected at lung-cancer conference on experimental drug combos

Medical Marketing and Media

Fri, 09/4/15 - 09:01 am

Bristol-Myers Squibb

AstraZeneca immune system drug wins orphan status in rare cancer

Yahoo/Reuters

Wed, 04/15/15 - 10:25 am

Pfizer's Selling, Not Buying, Pipeline Drugs?

Motley Fool

Thu, 10/6/11 - 09:29 am

Pages